T1	Disorder 10 29	Psoriatic arthritis
N1 	Reference T1 UMLS:C0003872	Psoriatic arthritis
T2	Disorder 43 54	lung cancer
N2 	Reference T2 UMLS:C1306460	lung cancer
N3 	Reference T2 UMLS:C0684249	lung cancer
T3	Disorder 57 76	Psoriatic arthritis
N4 	Reference T3 UMLS:C0003872	Psoriatic arthritis
T4	Disorder 83 105	inflammatory arthritis
N5 	Reference T4 UMLS:C0003864	inflammatory arthritis
T5	Disorder 122 131	psoriasis
N6 	Reference T5 UMLS:C0033860	psoriasis
T6	Disorder 164 175	lung cancer
N7 	Reference T6 UMLS:C1306460	lung cancer
N8 	Reference T6 UMLS:C0684249	lung cancer
T7	Disorder 211 213	RA
N9 	Reference T7 UMLS:C0003873	RA
T8	Disorder 217 226	psoriasis
N10 	Reference T8 UMLS:C0033860	psoriasis
T9	Disorder 256 275	psoriatic arthritis
N11 	Reference T9 UMLS:C0003872	psoriatic arthritis
T10	Disorder 292 303	lung cancer
N12 	Reference T10 UMLS:C1306460	lung cancer
N13 	Reference T10 UMLS:C0684249	lung cancer
T11	Disorder 338 357	psoriatic arthritis
N14 	Reference T11 UMLS:C0003872	psoriatic arthritis
T12	Disorder 374 385	lung cancer
N15 	Reference T12 UMLS:C1306460	lung cancer
N16 	Reference T12 UMLS:C0684249	lung cancer
T13	Disorder 459 477	pulmonary fibrosis
N17 	Reference T13 UMLS:C0034069	pulmonary fibrosis
T14	Pharmacological_substance 492 504	methotrexate
N1000 	Reference T14 MeSH:D008727	methotrexate
T15	Disorder 552 563	lung cancer
N18 	Reference T15 UMLS:C1306460	lung cancer
N19 	Reference T15 UMLS:C0684249	lung cancer
T16	Subject 197 205	patients
T18	Speculation_cue 513 518	might
